Bladder, Overactive Clinical Trials

1 recruitingLast updated: May 5, 2026

There are 10 actively recruiting bladder, overactive clinical trials across 5 countries. Studies span Not Applicable, Phase 4. Top locations include Taipei, Taiwan, Hanover, Maryland, United States, Chongqing, Chongqing Municipality, China. Updated daily from ClinicalTrials.gov.


Bladder, Overactive Trials at a Glance

10 actively recruiting trials for bladder, overactive are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Taipei, Hanover, and Chongqing. Lead sponsors running bladder, overactive studies include Mackay Memorial Hospital, KMUHIRB-F(I)-20230051, and Children's Hospital of Chongqing Medical University.

Browse bladder, overactive trials by phase

Treatments under study

About Bladder, Overactive Clinical Trials

Looking for clinical trials for Bladder, Overactive? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bladder, Overactive trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bladder, Overactive clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Not Applicable

Low-Energy Shock Wave Therapy for Overactive Bladder in Women With Metabolic Syndrome

Metabolic SyndromeLower Urinary Track SymptomsBladder+2 more
KMUHIRB-F(I)-2023005160 enrolled1 locationNCT07563764
Recruiting
Not Applicable

Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet

Overactive BladderUrinary Bladder, OveractiveUrinary Incontinence, Urge
Children's Hospital of Chongqing Medical University180 enrolled1 locationNCT06201013
Recruiting
Not Applicable

Ambulatory Long Length URodynamics Evaluation

Benign Prostatic HyperplasiaUrodynamicsUrinary Bladder, Overactive+4 more
Bright Uro101 enrolled7 locationsNCT07425015
Recruiting
Not Applicable

Comparison of the Efficacy of Perineal and Intravaginal Electrical Stimulation in Women With Idiopathic Overactive Bladder

Urinary Bladder, Overactive
Pamukkale University63 enrolled1 locationNCT07366918
Recruiting
Phase 4

Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder

Effect of DrugUrinary Bladder, Overactive
Mackay Memorial Hospital300 enrolled1 locationNCT06479720
Recruiting
Phase 4

Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity

Effect of DrugUrodynamicsUrinary Bladder, Overactive
Mackay Memorial Hospital300 enrolled1 locationNCT05968885
Recruiting
Phase 4

Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity

Effect of DrugUrinary Bladder, Overactive
Mackay Memorial Hospital200 enrolled1 locationNCT06197295
Recruiting

Elastographic Assessment of Suburethral Tissue in Continent and Incontinent Women

Urinary IncontinenceUrinary Incontinence, StressUrinary Bladder, Overactive+3 more
Szeged University80 enrolled1 locationNCT06933407
Recruiting

NXT Post-Market Clinical Follow-up

Urinary IncontinenceUrinary Bladder, NeurogenicUrinary Bladder, Overactive+2 more
Laborie Medical Technologies Inc.180 enrolled4 locationsNCT06336304
Recruiting
Phase 4

Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A

NocturiaUrinary Urge IncontinenceIncontinence, Urinary+3 more
University of South Florida60 enrolled2 locationsNCT04305743